First Time Loading...

Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 0.6845 USD -0.8%
Updated: May 2, 2024

Atara Biotherapeutics Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Atara Biotherapeutics Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Atara Biotherapeutics Inc
NASDAQ:ATRA
Interest Income Expense
$141k
CAGR 3-Years
-61%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$757m
CAGR 3-Years
35%
CAGR 5-Years
0%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.6B
CAGR 3-Years
-38%
CAGR 5-Years
-27%
CAGR 10-Years
-16%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$563.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$172.2m
CAGR 3-Years
7%
CAGR 5-Years
65%
CAGR 10-Years
N/A

See Also

What is Atara Biotherapeutics Inc's Interest Income Expense?
Interest Income Expense
141k USD

Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Interest Income Expense amounts to 141k USD.

What is Atara Biotherapeutics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-53%

Over the last year, the Interest Income Expense growth was -93%. The average annual Interest Income Expense growth rates for Atara Biotherapeutics Inc have been -61% over the past three years , -53% over the past five years .